EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Gene therapy for retinal diseases: From genetics to treatment

Ashish Khaparde, Grace P Mathias, B Poornachandra, M B Thirumalesh, Rohit Shetty, Arkasubhra Ghosh

Indian Journal of Ophthalmology · 2024-08 · 72 (8) · 1091-1101

DOI: 10.4103/ijo.ijo_2902_23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Indian Journal of Ophthalmology, online erschienen am 29.07.2024. Verfasst von Ashish Khaparde und 5 weiteren Autor:innen. Beteiligte Einrichtung: GROW Research Laboratory, Narayana Nethralaya Foundation, Manipal, Karnataka, India. Hauptthemen laut MEDLINE: Genetic Therapy, Retinal Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 105 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gene therapy approach for retinal disorders has been considered largely over the last decade owing to the favorable outcomes of the US Food and Drug Administration-approved commercial gene therapy, Luxturna. Technological advances in recent years, such as next-generation sequencing, research in molecular pathogenesis of retinal disorders, and precise correlations with their clinical phenotypes, have contributed to the progress of gene therapies for various diseases worldwide, and more recently in India as well. Thus, considerable research is being conducted for the right choice of vectors, transgene engineering, and accessible and cost-effective large-scale vector production. Many retinal disease-specific clinical trials are presently being conducted, thereby necessitating the collation of such information as a ready reference for the scientific and clinical community. In this article, we present an overview of existing gene therapy research, which is derived from an extensive search across PubMed, Google Scholar, and clinicaltrials.gov sources. This contributes to prime the understanding of basic aspects of this cutting-edge technology and information regarding current clinical trials across many different conditions. This information will provide a comprehensive evaluation of therapies in existing use/research for personalized treatment approaches in retinal disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyRetinal DiseasesHumansGenetic Vectors

Autor:innen und Institutionen

  • GROW Research Laboratory, Narayana Nethralaya Foundation, Manipal, Karnataka, India.
  • Manipal Academy of Higher Education, Manipal, Karnataka, India.
  • Department of Vitreo Retina Services, Narayana Nethralaya, Manipal, Karnataka, India.
  • Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bengaluru, Karnataka, India.

Zitieren

APA

Khaparde, A., Mathias, G. P., Poornachandra, B., Thirumalesh, M. B., Shetty, R., & Ghosh, A. (2024). Gene therapy for retinal diseases: From genetics to treatment. Indian Journal of Ophthalmology, 72(8), 1091-1101. https://doi.org/10.4103/ijo.ijo_2902_23

Vancouver

Khaparde A, Mathias GP, Poornachandra B, Thirumalesh MB, Shetty R, Ghosh A. Gene therapy for retinal diseases: From genetics to treatment. Indian Journal of Ophthalmology. 2024;72(8):1091-1101. doi:10.4103/ijo.ijo_2902_23

BibTeX
@article{Khaparde2024,
  author = {Khaparde, Ashish and Mathias, Grace P and Poornachandra, B and Thirumalesh, M B and Shetty, Rohit and Ghosh, Arkasubhra},
  title = {Gene therapy for retinal diseases: From genetics to treatment},
  journal = {Indian Journal of Ophthalmology},
  year = {2024},
  volume = {72},
  number = {8},
  pages = {1091--1101},
  doi = {10.4103/ijo.ijo_2902_23}
}
Kostenlos starten →